Evaluation of hepatitis C virus kits
- 1 November 1991
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 29 (11) , 2616-7
- https://doi.org/10.1128/jcm.29.11.2616-2617.1991
Abstract
Hepatitis C virus (HCV) antibodies were detected in 85.9% of the samples by commercial enzyme immunoassay (EIA) kits. Most EIA-positive samples were reactive (80%) by the RIBA HCV test (Ortho Diagnostics). Samples with optical density values greater than or equal to 2.0 were mostly reactive (87%) by RIBA HCV test, in contrast to those with values less than or equal to 1.0 (6.6%). Samples which were indeterminate by the RIBA HCV test were positive (88.4%) by HCV neutralization EIA (Abbott Laboratories), along with 29.4% of samples which were nonreactive by the RIBA HCV test.Keywords
This publication has 8 references indexed in Scilit:
- Early US experience with anti-HCV kit in blood donorsThe Lancet, 1990
- False-positive hepatitis C virus antibody tests in paraproteinaemiaThe Lancet, 1990
- Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virusThe Lancet, 1990
- Specificity of hepatitis C antibody ELISA in patients with haemophiliaThe Lancet, 1990
- False-positive anti-HCV tests in rheumatoid arthritisThe Lancet, 1990
- Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?The Lancet, 1990
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989